Metoprine NEW
| Price | $55 | $89 | $159 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Metoprine | CAS No.: 7761-45-7 |
| Purity: 99.09% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Metoprine |
| Description | Metoprine is a potent inhibitor of histamine N-methyltransferase (HMT), with potential antineoplastic activity. |
| In vivo | In mammals, histamine N-methyltransferase (HMT) is the sole enzyme responsible for degrading histamine in the brain.?Metoprine, one of the most potent HMT inhibitors, can cross the blood-brain barrier and increase brain histamine levels by inhibiting HMT.?Consequently, this compound can be a candidate for a prototype of drugs for the treatment of METH overdose[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 30.6 mg/mL (113.7 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.06 mg/mL (11.37 mM), Solution. 10% DMSO+90% Saline : < 3.06 mg/mL (11.37 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | N-methyltransferase | Metoprine | Inhibitor | inhibit | HMT | HistoneMethyltransferase | Histone Methyltransferase | HistamineReceptor | Histamine Receptor | histamine N-methyl transferase | histamine | diaminopyrimidine | BW 197U | blood-brain | barrier | antitumor | antifolate |
| Inhibitors Related | Undecane | Pemetrexed | MAK-683 hydrochloride | Meclizine dihydrochloride | Famotidine | Methotrexate disodium | Trimethoprim | Sodium butanoate | Alginic acid | Mianserin hydrochloride | Trazodone hydrochloride | Doxepin hydrochloride |
| Related Compound Libraries | Pain-Related Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY